Tiermodelle in der biomedizinischen Forschung

  • Carmen Birchmeier
  • Friedhelm Bladt
  • Stefan Britsch
Part of the Handbuch der Molekularen Medizin book series (HDBMOLEK, volume 1)


Tierversuche spielen seit langem eine unersetzliche Rolle bei der Erforschung der Grundlagen, der Vorbeugung und der Behandlungen von Erkrankungen. Sie sind unerläßlich für die Analyse komplexer physiologischer Prozesse und ihrer Kontrollmechanismen. Um molekulare Aspekte von physiologischen oder pathophysiologischen Prozessen zu verstehen, werden in den letzten Jahren vermehrt transgene Tiere eingesetzt.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aaronson S A (1991) Growth factors and cancer. Science 254:1146–1153PubMedGoogle Scholar
  2. Adler G, Herbay A von, Starlinger M (1993) Morbus Crohn colitis ulcerosa. Springer, Berlin Heidelberg New YorkGoogle Scholar
  3. Aldrovandi G M, Feuer G, Gao L, Jamieson B, Kristeva M, Chen I S, Zack J A (1993) The SCI D-hu mouse as a model for HIV-1 infection. Nature 363:732–736PubMedGoogle Scholar
  4. Angrist M, Kauffman E, Slaugenhaupt S A, Matise T C, Puffenberger E G, Washington S S, Lipson A, Cass D T, Reyna T, Weeks D E et al. (1993) A gene for Hirschsprung disease (megacolon) in the pericentromeric region of human chromosome 10. Nature Gen 4:351–356Google Scholar
  5. Bargmann C I, Hung M C, Weinberg R A (1986) The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 319:226–230PubMedGoogle Scholar
  6. Baynash A G, Hosoda K, Giaid A, Richardson J A, Emoto N, Hammer R E, Yanagisawa M (1994) Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 79:1277–1285PubMedGoogle Scholar
  7. Bolton D C, McKinley M P, Prusiner S B (1982) Identification of a protein that purifies with the scrapie prion. Science 218:1309–1311PubMedGoogle Scholar
  8. Borchelt D R, Scott M, Taraboulos A, Stahl N, Prusiner S B (1990) Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol 110:743–752PubMedGoogle Scholar
  9. Bosma G C, Custer R P, Bosma M J (1983) A severe combined immunodeficiency mutation in the mouse. Nature 301:527–530PubMedGoogle Scholar
  10. Bouchard L, Lamarre L, Tremblay P J, Jolicoeur P (1989) Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell 57:931–936PubMedGoogle Scholar
  11. Bradley A, Evans M, Kaufman M H, Robertson E (1984) Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 309:255–256PubMedGoogle Scholar
  12. Brown P, Gibbs C J, Rodgers J P, Asher D M, Sulima M P, Bacote A, Goldfarb L G, Gajdusek D C (1994) Human spongiform encephalopathy: the National institutes of health series of 300 cases of experimentally transmitted disease. Ann Neurol 35:513–529PubMedGoogle Scholar
  13. Bueler H, Aguzzi A, Sailer A, Greiner R A, Autenried P, Aguet M, Weissmann C (1993) Mice devoid of PrP are resistant to scrapie. Cell 73:1339–1347PubMedGoogle Scholar
  14. Carlson G A, Kingsbury D T, Goodman P A, Coleman S, Marshall S T, DeArmond S, Westaway D, Prusiner S B (1986) Linkage of prion protein and scrapie incubation time genes. Cell 46:503–511PubMedGoogle Scholar
  15. Carraway KB, Cantley L C (1994) A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell 78:5–8PubMedGoogle Scholar
  16. Carraway KB, Sliwkowski M X, Akita R, Platko J V, Guy P M, Nuijens A, Diamonti A J, Vandlen R L, Cantley L C, Cerione R A (1994) The erbB3 gene product is a receptor for heregulin. J Biol Chem 269:14303–14306PubMedGoogle Scholar
  17. Coleman D L (1978) Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14:141–148PubMedGoogle Scholar
  18. Coleman D L, Brodoff B N (1982) Spontaneous diabetes and obesity in rodents. In: Coleman D L, Brodoff B N (ed) Diabetes mellitus and obesity. Williams & Wilkins, Baltimore, pp 283–293Google Scholar
  19. Cordier A C, Haumont S M (1980) Development of thymus, parathyroids, and ultimo-branchial bodies in NMRI and nude mice. Am J Anat 157:227–263PubMedGoogle Scholar
  20. Costantini F, Lacy E (1981) Introduction of a rabbit betaglobin gene into the mouse germ line. Nature 294:92–94PubMedGoogle Scholar
  21. Custer R P, Bosma G C, Bosma M J (1985) Severe combined immunodeficiency (SCI D) in the mouse. Pathology, re-constitution, neoplasms. Am J Pathol 120:464–477PubMedGoogle Scholar
  22. Di Fiore P P, Pierce J H, Kraus M H, Segatto O, King C R, Aaronson S A (1987) erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 237:178–182PubMedGoogle Scholar
  23. Dietrich W F, Lander E S, Smith J S, Moser A R, Gould K A, Luongo C, Borenstein N, Dove W (1993) Genetic identification of mom-1, a major modifier locus affecting min-induced intestinal neoplasia in the mouse. Cell 75:631–639PubMedGoogle Scholar
  24. Doetschman T, Gregg R G, Maeda N, Hooper M L, Melton D W, Thompson S, Smithies O (1987) Targeted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature 330:576–578PubMedGoogle Scholar
  25. Dorshkind K, Keller G M, Phillips R A, Miller R G, Bosma G C, O’Toole M, Bosma M J (1984) Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease. J Immunol 132:1804–1808PubMedGoogle Scholar
  26. Douglas S A, Meek T D, Ohlstein E H (1994) Novel receptor antagonists welcome a new era in endothelin biology. Trends Pharmacol Sci 15:313–316PubMedGoogle Scholar
  27. Dunn L, Charles D (1937) Studies on spotting pattern. I. Analysis of quantitative variations in the pied spotting of the mouse. Genetics 22:14–42PubMedGoogle Scholar
  28. Edery P, Lyonnet S, Mulligan L M, Pelet A, Dow E, Abel L, Holder S, Nihoul F C, Ponder B A, Munnich A (1994) Mutations of the RET proto-oncogene in Hirschsprung’s disease. Nature 367:378–380PubMedGoogle Scholar
  29. Evans M J, Kaufman M H (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154–156PubMedGoogle Scholar
  30. Fearon E R, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759–767PubMedGoogle Scholar
  31. Flanagan S P (1966) ‘Nude’, a new hairless gene with pleiotropic effects in the mouse. Genet Res 8:295–309PubMedGoogle Scholar
  32. Fodde R, Edelmann W, Yang K, Van L C, Carlson C, Renault B, Breukel C, Alt E, Lipkin M, Khan P M et al. (1994) A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc Natl Acad Sci USA 91:8969–8973PubMedGoogle Scholar
  33. Fogh J, Giovanella B C (ed) (1982) The nude mouse in experimental and clinical research. Academic Press, New York LondonGoogle Scholar
  34. Gassmann M, Casagranda F, Orioli D, Simon H, Lai C, Klein R, Lemke G (1995) Aberrant neural and cardiac development in mice lacking the erbb4 neuregulin receptor. Nature 378:390–394PubMedGoogle Scholar
  35. Geer P van der, Pawson T (1995) The PTB domain: a new protein module implicated in signal transduction. Trends Biochem Sci 20:277–280PubMedGoogle Scholar
  36. Goodfellow P J (1994) Inherited cancers associated with the RET proto-oncogene. Curr Opin Genet Dev 4:446–452PubMedGoogle Scholar
  37. Gossler A, Doetschman T, Korn R, Serfling E, Kemler R (1986) Transgenesis by means of blastocyst-derived embryonic stem cell lines. Proc Natl Acad Sci USA 83:9065–9069PubMedGoogle Scholar
  38. Grieco M, Santoro M, Berlingieri M T, Melillo R M, Donghi R, Bongarzone I, Pierotti M A, Delia P G, Fusco A, Vecchio G (1990) PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60:557–563PubMedGoogle Scholar
  39. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M et al. (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589–600PubMedGoogle Scholar
  40. Gu H, Zou Y R, Rajewsky K (1993) Independent control of Immunoglobulin switch recombination at individual switch regions evidenced through CreloxP-mediated gene targeting. Cell 73:1155–1164PubMedGoogle Scholar
  41. Guy C T, Webster M A, Schaller M, Parsons T J, Cardiff R D, Müller W J (1992) Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 89:10578–10582PubMedGoogle Scholar
  42. Hanks M, Wurst W, Anson-Cartwright L, Auerbach A B, Joyner A L (1995) Rescue of the engrailed mutant phenotype by replacement of En-1 with En-2. Science 269:679–682PubMedGoogle Scholar
  43. Herberg L, Coleman D L (1977) Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism 26:59–99PubMedGoogle Scholar
  44. Hermiston M L, Gordon J I (1995) Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 270:1203–1207PubMedGoogle Scholar
  45. Heyningen V van (1994) Genetics. One gene — four syndromes. Nature 367:319–320PubMedGoogle Scholar
  46. Hofstra R M, Landsvater R M, Ceccherini I, Stulp R P, Stelwagen T, Luo Y, Pasini B, Hoppener J W, Van A H, Romeo G et al. (1994) A mutation in the RET protooncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367:375–376PubMedGoogle Scholar
  47. Hogan B, Costantini F, Lacy E (1986) Manipulating the mouse embryo. A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor NYGoogle Scholar
  48. Hollstein M, Sidransky D, Vogelstein B, Harris C C (1991) p53 mutations in human cancers. Science 253:49–53PubMedGoogle Scholar
  49. Holschneider A M, Meier R W, Ure B M (1994) Hirschsprung’s disease and allied disorders-a review. Eur J Pediatr Surg 4:260–266PubMedGoogle Scholar
  50. Hosoda K, Hammer R E, Richardson J A, Baynash A G, Cheung J C, Giaid A, Yanagisawa M (1994) Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 79:1267–1276PubMedGoogle Scholar
  51. Hsiao K, Baker H F, Crow T J, Poulter M, Owen F, Terwilliger J D, Westaway D, Ott J, Prusiner S B (1989) Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 338:342–345PubMedGoogle Scholar
  52. Hsiao K K, Groth D, Scott M, Yang S L, Serban H, Rapp D, Foster D, Torchia M, Dearmond S J, Prusiner S B (1994) Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc Natl Acad Sci USA 91:9126–9130PubMedGoogle Scholar
  53. Hülsken J, Behrens J, Birchmeier W (1994a) Tumor-suppressor gene products in cell contacts: the Cadherin-APC-armadillo connection. Curr Opin Cell Biol 6:711–716PubMedGoogle Scholar
  54. Hülsken J, Birchmeier W, Behrens J (1994b) E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J Cell Biol 127:2061–2069PubMedGoogle Scholar
  55. Hynes N E, Stern D F (1994) The biology of erbB-2/neu/ HER-2 and its role in cancer. Biochim Biophys Acta 1198:165–184PubMedGoogle Scholar
  56. Ito M, Miura S, Noda T (1995) Mouse model for familial adenomatous polyposis coli and APC gene. Tanpakushitsu Kakusan Koso 40:2035–2044PubMedGoogle Scholar
  57. Joyner A L (ed) (1993) Gene targeting a practical approach. The practical approach series. Oxford University Press, OxfordGoogle Scholar
  58. Kakiuchi H, Watanabe M, Ushijima T, Toyota M, Imai K, Weisburger J H, Sugimura T, Nagao M (1995) Specific 5′-GGGA-3′ → 5′-GGA-3′ mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Proc Natl Acad Sci USA 92:910–914PubMedGoogle Scholar
  59. Kapur R P (1993) Contemporary approaches toward understanding the pathogenesis of Hirschsprung disease. Pediatr Pathol 13:83–100PubMedGoogle Scholar
  60. Karunagaran D, Tzahar E, Liu N L, Wen D Z, Yarden Y (1995) Neu differentiation factor inhibits egf binding: a model for trans regulation within the erbb family of receptor tyrosine kinases. J Biol Chem 270:9982–9990PubMedGoogle Scholar
  61. Kindred B (1981) Deficient and sufficient immune systems in nude mouse. In: Gershwin M E, Merchant B (ed) Immunological defects in laboratory animals. Plenum Press, New York, pp 215–265Google Scholar
  62. King C R, Kraus M H, Aaronson S A (1985) Amplification of a novel verbB-related gene in a human mammary carcinoma. Science 229:974–976PubMedGoogle Scholar
  63. King C R, Borrello I, Bellot F, Comoglio P, Schlessinger J (1988) EGF binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3. EMBO J 7:1647–1651PubMedGoogle Scholar
  64. Kinzler K W, Nilbert M C, Su L K, Vogelstein B, Bryan T M, Levy D B, Smith K J, Preisinger A C, Hedge P, McKechnie D et al. (1991) Identification of FAP locus genes from chromosome 5q21. Science 253:661–665PubMedGoogle Scholar
  65. Knudson A J (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820–823PubMedGoogle Scholar
  66. Krege J H, John S W, Langenbach L L, Hodgin J B, Hagaman J R, Bachman E S, Jennette J C, O’Brien D A, Smithies O (1995) Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 375:146–148PubMedGoogle Scholar
  67. Kühn R, Lohler J, Rennick D, Rajewsky K, Müller W (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263–274PubMedGoogle Scholar
  68. Kühn R, Schwenk F, Aguet M, Rajewsky K (1995) Inducible gene targeting in mice. Science 269:1427–1429PubMedGoogle Scholar
  69. Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, Oda H, Kuwaki T, Cao W H, Kamada N et al. (1994) Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368:703–710PubMedGoogle Scholar
  70. Laird P W, Jackson G L, Fazeli A, Dickinson S L, Jung W E, Li E, Weinberg R A, Jaenisch R (1995) Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81:197–205PubMedGoogle Scholar
  71. Land H, Parada L F, Weinberg R A (1983) Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304:596–602PubMedGoogle Scholar
  72. Lane P (1966) Association of megacolon with two recessive spotting genes in the mouse. J Hered 57:29–31PubMedGoogle Scholar
  73. Lee K F, Simon H, Chen H, Bates B, Hung M C, Hauser C (1995) Requirement for neuregulin receptor erbb2 in neural and cardiac development. Nature 378:394–398PubMedGoogle Scholar
  74. Leppert M, Burt R, Hughes J P, Samowitz W, Nakamura Y, Woodward S, Gardner E, Lalouel J M, White R (1990) Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. N Engl J Med 322:904–908PubMedGoogle Scholar
  75. Li E, Bestor T H, Jaenisch R (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69:915–926PubMedGoogle Scholar
  76. Lynch H T, Smyrk T C, Watson P, Lanspa S J, Lynch P M, Jenkins J X, Rouse J, Cavalieri J, Howard L, Lynch J (1992) Hereditary flat adenoma syndrome: a variant of familial adenomatous polyposis? Dis Colon Rectum 35:411–421PubMedGoogle Scholar
  77. Lyon M F, Rastan S, Brown S D M (ed) (1996) Genetic variants and strains of the laboratory mouse. Oxford University Press, OxfordGoogle Scholar
  78. Lyonnet S, Bolino A, Pelet A, Abel L, Nihoul F C, Briard M L, Mok S V, Kaariainen H, Martucciello G, Lerone M et al. (1993) A gene for Hirschsprung disease maps to the proximal long arm of chromosome 10. Nature Gen 4:346–350Google Scholar
  79. MacPhee M, Chepenik K P, Liddell R A, Nelson K K, Siracusa L D, Buchberg A M (1995) The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell 81:957–966PubMedGoogle Scholar
  80. Magnuson T, Epstein C J, Silver L M, Martin G R (1982) Pluripotent embryonic stem cell lines can be derived from tw5/tw5 blastocysts. Nature 298:750–753PubMedGoogle Scholar
  81. Mansour S L, Thomas K R, Capecchi M R (1988) Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336:348–352PubMedGoogle Scholar
  82. Marchionni M A (1995) Cell-cell signalling neu tack on neuregulin. Nature 378:334–335PubMedGoogle Scholar
  83. Meyer D, Birchmeier C (1995) Multiple essential functions of neuregulin in development. Nature 378:386–390PubMedGoogle Scholar
  84. Mombaerts P, Mizoguchi E, Grusby M J, Glimcher L H, Bhan A K, Tonegawa S (1993) Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75:274–282PubMedGoogle Scholar
  85. Moser A R, Pitot H C, Dove W F (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247:322–324PubMedGoogle Scholar
  86. Moser A R, Dove W F, Roth K A, Gordon J I (1992) The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. J Cell Biol 116:1517–1526PubMedGoogle Scholar
  87. Moser A R, Shoemaker A R, Connelly C S, Clipson L, Gould K A, Luongo C, Dove W F, Siggers P H, Gardner R L (1995) Homozygosity for the Min allele of Apc results in disruption of mouse development prior to gastrulation. Dev Dyn 203:422–433PubMedGoogle Scholar
  88. Müller W J, Sinn E, Pattengale P K, Wallace R, Leder P (1988) Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54:105–115PubMedGoogle Scholar
  89. Mulligan L M, Kwok J B, Healey C S, Elsdon M J, Eng C, Gardner E, Love D R, Mole S E, Moore J K, Papi L, et al. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458–460PubMedGoogle Scholar
  90. Mullins J J, Peters J, Ganten D (1990) Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344:541–544PubMedGoogle Scholar
  91. Nehls M, Pfeifer D, Schorpp M, Hedrich H, Boehm T (1994) New member of the winged-helix protein family disrupted in mouse and rat nude mutations. Nature 372:103–107PubMedGoogle Scholar
  92. Nikitin A, Ballering L A, Lyons J, Rajewsky M F (1991) Early mutation of the neu (erbB-2) gene during ethylnitrosourea-induced oncogenesis in the rat Schwann cell lineage. Proc Natl Acad Sci USA 88:9939–9943PubMedGoogle Scholar
  93. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, Koyama K, Utsunomiya J, Baba S, Hedge P (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253:665–669PubMedGoogle Scholar
  94. Nocka K, Tan J C, Chiu E, Chu T Y, Ray P, Traktman P, Besmer P (1990) Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J 9:1805–1813PubMedGoogle Scholar
  95. Pachnis V, Mankoo B, Costantini F (1993) Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119:1005–1017PubMedGoogle Scholar
  96. Palmiter R D, Brinster R L, Hammer R E, Trumbauer M E, Rosenfeld M G, Birnberg N C, Evans R M (1982) Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature 300:611–615PubMedGoogle Scholar
  97. Pantelouris E M (1968) Absence of thymus in a mouse mutant. Nature 217:370–371PubMedGoogle Scholar
  98. Pantelouris E M (1973) Athymic development in the mouse. Differentiation 1:437–450PubMedGoogle Scholar
  99. Parada L F, Land H, Weinberg R A, Wolf D, Rotter V (1984) Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature 312:649–651PubMedGoogle Scholar
  100. Peles E, Ben L R, Tzahar E, Liu N, Wen D, Yarden Y (1993) Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships. EMBO J 12:961–971PubMedGoogle Scholar
  101. Peltomaki P, Aaltonen L A, Sistonen P, Pylkkanen L, Mecklin J P, Jarvinen H, Green J S, Jass J R, Weber J L, Leach F S et al. (1993) Genetic mapping of a locus predisposing to human colorectal cancer. Science 260:810–812PubMedGoogle Scholar
  102. Plowman G D, Green J M, Culouscou J M, Carlton G W, Rothwell V M, Buckley S (1993) Heregulin induces tyrosine phosphorylation of HER4/pl80erbB4. Nature 366:473–475PubMedGoogle Scholar
  103. Polakis P (1995) Mutations in the APC gene and their implications for protein structure and function. Curr Opin Genet Dev 5:66–71PubMedGoogle Scholar
  104. Prusiner S B (1995) The prion diseases. Sci Am 272:48–51PubMedGoogle Scholar
  105. Prusiner S B, Hsiao K K (1994) Human prion diseases. Ann Neurol 35:385–395PubMedGoogle Scholar
  106. Prusiner S B, Groth D F, Bolton D C, Kent S B, Hood L E (1984) Purification and structural studies of a major scrapie prion protein. Cell 38:127–134PubMedGoogle Scholar
  107. Prusiner S B, Groth D, Serban A, Koehler R, Foster D, Torchia M, Burton D, Yang S L, DeArmond S J (1993) Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci USA 90:10608–10612PubMedGoogle Scholar
  108. Puffenberger E G, Hosoda K, Washington S S, Nakao K, Wit D de, Yanagisawa M, Chakravart A (1994) A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung’s disease. Cell 79:1257–1266PubMedGoogle Scholar
  109. Romeo G, Ronchetto P, Luo Y, Barone V, Seri M, Ceccherini I, Pasini B, Bocciardi R, Lerone M, Kaariainen H et al. (1994) Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung’s disease. Nature 367:377–378PubMedGoogle Scholar
  110. Rubanyi G M, Polokoff M A (1994) Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46:325–415PubMedGoogle Scholar
  111. Rubin E M, Smith D J (1994) Atherosclerosis in mice: getting to the heart of a polygenic disorder. Trends Genet 10:199–203PubMedGoogle Scholar
  112. Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain S H, Masiarz F R, Munemitsu S, Polakis P (1993) Association of the APC gene product with beta-catenin. Science 262:1731–1734PubMedGoogle Scholar
  113. Rubinfeld B, Souza B, Albert I, Munemitsu S, Polakis P (1995) The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin. J Biol Chem 270:5549–5555PubMedGoogle Scholar
  114. Sadlack B, Merz H, Schorle H, Schimpl A, Feller A C, Horak I (1993) Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253–261PubMedGoogle Scholar
  115. Safar J, Roller P P, Gajdusek D C, Gibbs C J (1993) Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J Biol Chem 268:20276–20284PubMedGoogle Scholar
  116. Sakaguchi S, Katamine S, Nishida N, Moriuchi R, Shigematsu K, Sugimoto T, Nakatani A, Kataoka Y, Houtani T, Shirabe S, Okada H, Hasegawa S, Miyamoto T, Noda T (1996) Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 380:528531Google Scholar
  117. Santoro M, Rosati R, Grieco M, Berlingieri M T, D’Amato G L, Franciscis V de, Fusco A (1990) The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene 5:1595–1598PubMedGoogle Scholar
  118. Schenkel J (1995) Transgene Tiere. Spektrum, HeidelbergGoogle Scholar
  119. Schlessinger J, Ullrich A (1992) Growth factor signaling by receptor tyrosine kinases. Neuron 9:383–391PubMedGoogle Scholar
  120. Schuchardt A, D’Agati V, Larsson B L, Costantini F, Pachnis V (1994) Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor ret. Nature 367:380–383PubMedGoogle Scholar
  121. Shih C, Shilo B Z, Goldfarb M P, Dannenberg A, Weinberg R A (1979) Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc Natl Acad Sci USA 76:5714–5718PubMedGoogle Scholar
  122. Slamon D J, Clark G M, Wong S G, Levin W J, Ullrich A, McGuire W L (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177–182PubMedGoogle Scholar
  123. Sliwkowski M X, Schaefer G, Akita R W, Lofgren J A, Fitzpatrick V D, Nuijens A, Fendly B M, Cerione R A, Vandlen R L, Carraway K (1994) Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem 269:14661–14665PubMedGoogle Scholar
  124. Smith A G, Heath J K, Donaldson D D, Wong G G, Moreau J, Stahl M, Rogers D (1988) Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336:688–690PubMedGoogle Scholar
  125. Songyang Z, Carraway K, Eck M J, Harrison S C, Feldman R A, Mohammadi M, Schlessinger J, Hubbard S R, Smith D P, Eng C et al. (1995) Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373:536–539PubMedGoogle Scholar
  126. Spirio L, Otterud B, Stauffer D, Lynch H, Lynch P, Watson P, Lanspa S, Smyrk T, Cavalieri J, Howard L et al. (1992) Linkage of a variant or attenuated form of adenomatous Polyposis coli to the adenomatous polyposis coli (APC) locus. Am J Hum Genet 51:92–100PubMedGoogle Scholar
  127. Stahl N, Borchelt D R, Hsiao K, Prusiner S B (1987) Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51:229–240PubMedGoogle Scholar
  128. Steward T A, Wagner E F, Mintz B (1982) Human betaglobin gene sequences injected into mouse eggs, retained in adults, and transmitted to progeny. Science 217:1046–1048PubMedGoogle Scholar
  129. Strober W, Ehrhardt R O (1993) Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice. Cell 75:203–205PubMedGoogle Scholar
  130. Su L K, Kinzler K W, Vogelstein B, Preisinger A C, Moser A R, Luongo C, Gould K A, Dove W F (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256:668–670PubMedGoogle Scholar
  131. Su L K, Vogelstein B, Kinzler K W (1993) Association of the APC tumor suppressor protein with catenins. Science 262:1734–1737PubMedGoogle Scholar
  132. Takahashi M, Ritz J, Cooper G M (1985) Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 42:581–588PubMedGoogle Scholar
  133. Taylor D M (1993) Inactivation of SE agents. Br Med Bull 49:810–821PubMedGoogle Scholar
  134. Thomas K R, Capecchi M R (1987) Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51:503–512PubMedGoogle Scholar
  135. Tzahar E, Levkowitz G, Karunagaran D, Yi L, Peles E, Lavi S, Chang D, Liu N L, Yayon A, Wen D Z, Yarden Y (1994) Erbb-3 and erbb-4 function as the respective low and high affinity receptors of all neu differentiation factor heregulin isoforms. J Biol Chem 269:25226–25233PubMedGoogle Scholar
  136. Vilet E van, Jenkinson E J, Kingston R, Owen J J, Ewijk W van (1985) Stromal cell types in the developing thymus of the normal and nude mouse embryo. Eur J Immunol 15:675–681Google Scholar
  137. Vogelstein B, Kinzler K W (1994) Colorectal cancer and the intersection between basic and clinical research. Cold Spring Harb Symp Quant Biol 59:517–521PubMedGoogle Scholar
  138. Wallasch C, Weiss F U, Niederfellner G, Jallal B, Issing W, Ullrich A (1995) Heregulin-dependent regulation of her2/ neu oncogenic signaling by heterodimerization with her3. EMBO J 14:4267–4275PubMedGoogle Scholar
  139. Wassarman P M, DePamphilis M L (ed) (1993) Guide to techniques in mouse development. Methods in enzymology. Academic Press, New York LondonGoogle Scholar
  140. Weinberg R A (1991) Tumor suppressor genes. Science 254:1138–1146PubMedGoogle Scholar
  141. Weissmann C (1991) A ‘unified theory’ of prion propagation. Nature 352:679–683PubMedGoogle Scholar
  142. Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T, Toyoshima K (1986) Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 319:230–234PubMedGoogle Scholar
  143. Yanagisawa M (1994) The endothelin system. A new target for therapeutic intervention. Circulation 89:1320–1322PubMedGoogle Scholar
  144. Yarden Y, Ullrich A (1988) Growth factor receptor tyrosine kinases. Ann Rev Biochem 57:443–478PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • Carmen Birchmeier
  • Friedhelm Bladt
  • Stefan Britsch

There are no affiliations available

Personalised recommendations